Quantifying the Progression of Stargardt Disease in Double-Null ABCA4 Carriers Using Fundus Autofluorescence Imaging
Our methodology provides a quantitative tool for investigating the natural progression of the Stargardt disease, and, potentially, the effects of genotype, environment, and therapeutic intervention on its course.
Authors
- Tomislav Glavan
- Anne B. Fulton (ORCID: https://orcid.org/0000-0002-5752-2614)
- Sigrid Aslaksen (ORCID: https://orcid.org/0000-0003-2349-7884)
- Annie M. Lancos
- Ivana Mihalek
- Laurie L. Molday (ORCID: https://orcid.org/0000-0003-4806-6327)
- Katarzyna Malendowicz
- Hanna De Bruyn (ORCID: https://orcid.org/0000-0002-9515-9086)
- Robert S. Molday (ORCID: https://orcid.org/0000-0002-4479-1831)
- Chiara Ciolfi (ORCID: https://orcid.org/0000-0003-1952-1247)
Institutions
- Boston Children's Hospital (US)
- Harvard University (US)
- University of British Columbia (CA)
- University of Rijeka (HR)
Publication Details
- Journal
- Translational Vision Science & Technology
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1167/tvst.14.3.16
- Citations
- 1
- Primary Topic
- Retinal Development and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- National Institutes of Health
- Canadian Institutes of Health Research
- National Eye Institute